Jared Gollob - Net Worth and Insider Trading

Jared Gollob Net Worth

The estimated net worth of Jared Gollob is at least $5 Million dollars as of 2024-11-05. Jared Gollob is the Chief Medical Officer of Kymera Therapeutics Inc and owns about 95,470 shares of Kymera Therapeutics Inc (KYMR) stock worth over $5 Million. Details can be seen in Jared Gollob's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jared Gollob has not made any transactions after 2024-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jared Gollob

To

Jared Gollob Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jared Gollob owns 1 companies in total, including Kymera Therapeutics Inc (KYMR) .

Click here to see the complete history of Jared Gollob’s form 4 insider trades.

Insider Ownership Summary of Jared Gollob

Ticker Comapny Transaction Date Type of Owner
KYMR Kymera Therapeutics Inc 2024-07-16 Chief Medical Officer

Jared Gollob Latest Holdings Summary

Jared Gollob currently owns a total of 1 stock. Jared Gollob owns 95,470 shares of Kymera Therapeutics Inc (KYMR) as of July 16, 2024, with a value of $5 Million.

Latest Holdings of Jared Gollob

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KYMR Kymera Therapeutics Inc 2024-07-16 95,470 47.30 4,515,731

Holding Weightings of Jared Gollob


Jared Gollob Form 4 Trading Tracker

According to the SEC Form 4 filings, Jared Gollob has made a total of 8 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 39,600 shares on July 16, 2024, which brought Jared Gollob around $2 Million.

Insider Trading History of Jared Gollob

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jared Gollob Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jared Gollob Ownership Network

Ownership Network List of Jared Gollob

No Data

Ownership Network Relation of Jared Gollob

Insider Network Chart

Jared Gollob Owned Company Details

What does Kymera Therapeutics Inc do?

Who are the key executives at Kymera Therapeutics Inc?

Jared Gollob is the Chief Medical Officer of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Operating Officer Jeremy G Chadwick , 10 percent owner Atlas Venture Fund X, L.p. , and Chief Financial Officer Bruce N. Jacobs .

Kymera Therapeutics Inc (KYMR) Insider Trades Summary

Over the past 18 months, Jared Gollob made 4 insider transaction in Kymera Therapeutics Inc (KYMR) with a net sale of 89,481. Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 20,000 shares made by Jeffrey W. Albers , and a net purchase of 414,105 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kymera Therapeutics Inc Insider Transactions

No Available Data

Jared Gollob Mailing Address

Above is the net worth, insider trading, and ownership report for Jared Gollob. You might contact Jared Gollob via mailing address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards, Suite 230, Watertown Ma 02472.